quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:54:37·43d
ANALYSTRating
Prime Medicine Inc. logo

Oppenheimer initiated coverage on Prime Medicine with a new price target

PRME· Prime Medicine Inc.
Health Care
Original source

Companies

  • PRME
    Prime Medicine Inc.
    Health Care

Recent analyst ratings

  • Mar 12UpdateOppenheimer$11.00
  • May 27UpdateCitigroup$1.50
  • May 20UpdateAnalyst-
  • May 20UpdateH.C. Wainwright-
  • Dec 10UpdateJMP Securities$10.00
  • May 20UpdateH.C. Wainwright$10.00

Related

  • SEC1d
    SEC Form DEFA14A filed by Prime Medicine Inc.
  • SEC1d
    SEC Form DEF 14A filed by Prime Medicine Inc.
  • INSIDER6d
    SEC Form 4 filed by Makhni Svetlana Ni
  • INSIDER6d
    SEC Form 3 filed by new insider Makhni Svetlana Ni
  • SEC8d
    Prime Medicine Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
  • PR8d
    Prime Medicine Appoints Svetlana Makhni as Chief Financial Officer
  • SEC50d
    SEC Form EFFECT filed by Prime Medicine Inc.
  • SEC52d
    SEC Form S-8 filed by Prime Medicine Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022